Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study

BACKGROUND: Anaemia is a very common problem in patients with end-stage kidney disease (ESKD) and the use of erythropoietin-stimulating agents (ESA) has revolutionised its treatment. Residual renal function (RRF) is associated with a reduction in ESA resistance and mortality in chronic dialysis. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Louw, Elizabeth Helene, Chothia, Mogamat-Yazied
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702117/
https://www.ncbi.nlm.nih.gov/pubmed/29178879
http://dx.doi.org/10.1186/s12882-017-0752-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702117/
https://www.ncbi.nlm.nih.gov/pubmed/29178879
http://dx.doi.org/10.1186/s12882-017-0752-x

Ejemplares similares